ABCG1 - A potential therapeutic target for atherosclerosis

被引:3
|
作者
Ni, Zhan-ling [1 ]
Zhao, Shui-ping [1 ]
Wu, Zhihong [1 ]
机构
[1] Cent S Univ, Xiangya Hosp 2, Dept Cardiol, Changsha 410011, Peoples R China
关键词
D O I
10.1016/j.mehy.2006.06.042
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cholesterol efflux from macrophage foam cells, the initial step of reverse cholesterol transport, is assumed to be the most relevant step with respect to atherosclerosis. As one of the ATP-binding cassette transporter (ABC) family members, ABCG1 plays a critical role in the process of cholesterol efflux. It has been recently identified to export cellular cholesterol to large HDL particles. For mature HDL constitutes the bulk of the plasma HDL, ABCG1 is responsible for the majority of the cholesterol efflux from macrophage foam cells to serum. Overexpression of ABCG1 improves HDL function through stimulating cholesterol export. Therefore, it could be hypothesized that ABCG1 would be a new target for the treatment of atherosclerosis. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:214 / 217
页数:4
相关论文
共 50 条
  • [41] Hypomethylation of ABCG1 in peripheral blood as a potential marker for the detection of coronary heart disease
    Jin, Jialie
    Zhao, Xiaojing
    Zhu, Chao
    Li, Mengxia
    Wang, Jinxin
    Fan, Yao
    Liu, Chunlan
    Shen, Chong
    Yang, Rongxi
    [J]. CLINICAL EPIGENETICS, 2023, 15 (01)
  • [42] Structure of the Human Cholesterol Transporter ABCG1
    Skarda, Liga
    Kowal, Julia
    Locher, Kaspar P.
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2021, 433 (21)
  • [43] Emerging Piezo1 signaling in inflammation and atherosclerosis; a potential therapeutic target
    Shinge, Shafiu A. Umar
    Zhang, Daifang
    Ud Din, Ahmad
    Yu, FengXu
    Nie, YongMei
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (03): : 923 - 941
  • [44] Interleukin-22: a potential therapeutic target in atherosclerosis
    Luo, Jin-Wen
    Hu, Yuan
    Liu, Jian
    Yang, Huan
    Huang, Peng
    [J]. MOLECULAR MEDICINE, 2021, 27 (01)
  • [45] Circadian Rhythm: Potential Therapeutic Target for Atherosclerosis and Thrombosis
    Man, Andy W. C.
    Li, Huige
    Xia, Ning
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (02) : 1 - 19
  • [46] Histone Deacetylase 3: A Potential Therapeutic Target for Atherosclerosis
    Jiang, Li-Ping
    Yu, Xiao-Hua
    Chen, Jin-Zhi
    Hu, Mi
    Zhang, Yang-Kai
    Lin, Hui-Ling
    Tang, Wan-Ying
    He, Ping-Ping
    Ouyang, Xin-Ping
    [J]. AGING AND DISEASE, 2022, 13 (03): : 773 - 786
  • [47] 12/15-lipoxygenase increases the degradation of ABCG1 through PEST sequence-targeted proteolysis of ABCG1
    Nagelin, Melissa H.
    Srinivasan, Suseela
    Nadler, Jerry L.
    Hedrick, Catherine C.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E47 - E47
  • [48] Interleukin-22: a potential therapeutic target in atherosclerosis
    Jin-Wen Luo
    Yuan Hu
    Jian Liu
    Huan Yang
    Peng Huang
    [J]. Molecular Medicine, 2021, 27
  • [49] Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis
    Li, Jing
    Taylor, Angela M.
    Manichaikul, Ani
    Angle, John F.
    Shi, Weibin
    [J]. CELLS, 2022, 11 (07)
  • [50] Apolipoprotein A-IV: A potential therapeutic target for atherosclerosis
    Peng, Jia
    Li, Xiang-ping
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2018, 139 : 87 - 92